Hyderabad-based Nucelion Therapeutics and Bengaluru's Pandorum Technologies have partnered to advance two PRIP-backed ophthalmology projects targeting advanced keratopathy and wet age-related macular degeneration. The projects have a combined planned outlay of Rs. 16.97 crore, including up to Rs. 8 crore in PRIP funding
Pandorum Technologies has partnered with Bharat Biotech arm Nucelion Therapeutics to expand manufacturing of its exosome-based regenerative therapies across the Asia-Pacific region, strengthening regional supply, regulatory readiness and India’s biologics manufacturing capabilities
